**Pipeline Telemetry**<br>
Arize Phoenix trace — capturing token consumption, latency, and per-skill cost breakdown for this encounter.
![Case 6 Diabetes Screen](../../images/Case%2006_Diabetes.jpeg)


# Case 06: Diabetes

A diabetes follow-up visit where the patient reported home glucose readings and an in-office fasting blood sugar value.

##  🤖 1. Telemetry & AI Note Analysis:

The generation layer suffered a severe data extraction failure in the Objective ("O") segment. While it correctly noted the negative review of systems in the Subjective block, it actively claimed that "no specific measurements or findings are mentioned." This completely erased the patient's home glucose trend ($\le$ 135 mg/dL) and the active in-office fasting blood sugar reading (120 mg/dL) taken during the consult.

---

## ⚖️ 2. Meta-Evaluation: Judge & Dataset Audit
Unlike previous runs where the automated evaluator demonstrated clinical blind spots, the Gemini judge performed accurately on this case:
- Accurate Identification of Active Misrepresentation: A weaker evaluation framework might have flagged this purely as a missing detail (Completeness failure). However, the judge correctly recognized that by stating "no measurements are mentioned," the agent introduced an active falsehood into the documentation. The judge properly penalized Faithfulness (2/5) alongside Completeness (1/5), successfully gating the unsafe note.

---

## ⚠️ 3. Clinical Liability & Systemic Risk:

In the clinical management of Diabetes Mellitus, objective numerical trends are the foundational pillars of tracking disease control and adjusting medication dosages.

By stripping out the glucose readings 135 and 120 and stating that no measurements exist, the agent introduces a severe systemic liability. If this note were automatically uploaded into an Electronic Health Record (EHR), a reviewing clinician would assume the patient is non-compliant with home monitoring or that the clinic failed to run routine checks. This could trigger redundant laboratory orders or lead to dangerous delays in insulin or oral hypoglycemic adjustments due to an apparent lack of data. This case serves as a prime example of why an ambient scribe must possess a zero-tolerance threshold for dropping numerical clinical values before deployment.


---

## Key Takeaway:
Claiming "no measurements were mentioned" while erasing two real glucose values risks a falsse treatment planning moving forward.
